Common cold sore drug tested as potential Alzheimer's slowing treatment
NCT ID NCT03282916
Summary
This study tested whether a high dose of the common antiviral drug Valtrex (valacyclovir), used to treat herpes, could slow the progression of mild Alzheimer's disease. It involved 130 patients who had both Alzheimer's and evidence of a herpes simplex virus infection. Over 18 months, researchers compared the drug to a placebo to see if it helped preserve memory and thinking skills and reduced brain changes linked to Alzheimer's.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Banner Alzheimer's Institute (BAI)
Phoenix, Arizona, 85006, United States
-
New York State Psychiatric Institute
New York, New York, 10032, United States
-
New York University School of Medicine
New York, New York, 10016, United States
Conditions
Explore the condition pages connected to this study.